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The excellent review by Al-Ani et al reflects a consensus approach to management of 
inflammatory bowel disease during the SARS-CoV-2 pandemic that has been established 
remarkably rapidly by very effective international collaboration.1 Much of the focus has 
appropriately been on the potential impact of immuno-modulating therapies. We would also like 
to highlight the potential importance of nutrition and particularly vitamin D as raised by Panarese 
and Shahini.2 
There are marked variations in mortality from COVID-19 between different countries. It is 
becoming clear that countries in the Southern Hemisphere are seeing a relatively low mortality 
(Figure and Table).2,3 It could be argued that the virus spread later to the Southern Hemisphere 
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by this argument looks increasingly weak. In Australia 100 cases were reported by 10th March, 
1000 by 21st March; in the UK the first 100 had been reported by 5th March and the first 1000 by 
14th March, just one week earlier. If one compares the mortality (68 per million) in the UK by 3rd 
April with the mortality (2 per million) in Australia by 10th April there is still a huge discrepancy. 
When mortality per million is plotted against latitude it can be seen that all countries that lie 
below 35 degrees North have relatively low mortality. Thirty-five degrees North also happens to 
be the latitude above which people do not receive sufficient sunlight to retain adequate vitamin 
D levels during winter. This suggests a possible role for vitamin D in determining outcomes from 
COVID-19. There are outliers of course – mortality is relatively low in Nordic countries – but there 
vitamin D deficiency is relatively uncommon, probably due to widespread use of supplements.4 
Italy and Spain, perhaps surprisingly, have relatively high prevalences of vitamin D deficiency. 
Vitamin D deficiency has also been shown to correlate with hypertension,5 diabetes,6 obesity,7 
and ethnicity8 – all features associated with increased risk of severe COVID-19.
There are considerable experimental data showing that vitamin D is important in regulating and 
suppressing the inflammatory cytokine response of respiratory epithelial cells and macrophages 
to various pathogens including respiratory viruses.9 Evidence that vitamin D might protect 
against infection is modest but it is important to note that the hypothesis is not that vitamin D 
would protect against SARS-CoV-2 infection but that it could be very important in preventing the 
cytokine storm and subsequent Acute Respiratory Distress Syndrome that is commonly the cause 
of mortality.10
Research is urgently needed to assess whether there may be a correlation between vitamin D 
status and severity of COVID-19 disease. Meanwhile the evidence supporting a protective effect 
of vitamin D against severe COVID-19 disease is very suggestive, a substantial  proportion of the 
population in the Northern Hemisphere will currently be vitamin D deficient, and supplements eg 
1000 units per day are very safe. It is time for governments to strengthen recommendations for 
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Legend to Figure:
Correlation between mortality from COVID-19 per million by country and latitude. All countries 
with >150 cases included. Data are from https://www.worldometers.info/coronavirus/ 3 accessed 
15th April 2020. Latitude is for capital city. It can be seen that mortality is relatively low at 
latitudes less than 35 degrees North, the point below which adequate sunlight is likely to have 
been received to maintain vitamin D levels during the winter. Correlation between mortality and 
latitude r=0.53, P<0.0001 by Spearman’s rank correlation.
Table:
Comparison between latitude (of capital city in each country) and mortality from COVID-19 per 
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 Iceland 64 1720 8 23 
Faeroe 62 184 0 0 
Norway 60 6740 145 27 
Finland 60 3237 64 12 
Sweden 59 11927 1203 119 
Estonia 59 1400 35 26 
Latvia 57 666 5 3 
 Russia 56 24490 198 1 
Denmark 56 6681 309 53 
Lithuania 55 1091 29 11 
Belarus 54 3728 36 4 
Isle of Man 54 256 4 47 
Ireland 53 11479 406 82 
Germany 52 132321 3502 42 
 UK 52 93873 12107 178 
Netherlands 52 28153 3134 183 
 Poland 52 7408 268 7 
Belgium 51 33573 4440 383 
 Czechia 50 6151 163 15 
Luxembourg 50 3307 67 107 
 Ukraine 50 3764 108 2 
 France 49 143303 15729 241 
 Channel 
Islands 
49 445 13 75 
Austria 48 14321 393 44 
Slovakia 48 863 6 1 
Switzerland 47 26336 1221 141 
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Hungary 47 1579 134 14 
Kazakhstan 47 1290 16 0.9 
 Croatia 46 1741 34 8 
 Slovenia 46 1248 61 29 
 Serbia 45 4873 99 11 
Canada 44 27063 903 24 
 Romania 44 7216 362 19 
Bosnia and 
Herzegovina 
44 1110 41 12 
San Marino 44 372 36 1061 
 Bulgaria 43 735 36 5 
Kyrgyzstan 43 449 5 0.8 
Italy 42 162488 21067 348 
North 
Macedonia 
42 974 45 22 
Andorra 42 659 31 401 
Montenegro 42 288 4 6 
Georgia 42 306 3 0.8 
USA 41 614246 26064 79 
 Turkey 41 65111 1403 17 
 Uzbekistan 41 1275 4 0.1 
Albania 41 494 25 9 
Spain 40 177633 18579 397 
China 40 82295 3342 2 
Azerbaijan 40 1253 13 1 
Armenia 40 1111 17 6 
Portugal 39 18091 599 59 
 S. Korea 38 10591 225 4 
Greece 38 2170 101 10 
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 Iran 36 76389 4777 57 
 Japan 36 8100 146 1 
Malta 36 399 3 7 
Cyprus 35 695 12 10 
 Afghanistan 35 784 25 0.6 
 Pakistan 34 5988 107 0.5 
Tunisia 34 747 34 3 
Lebanon 34 658 21 3 
 Iraq 33 1400 78 2 
Israel 32 12200 126 15 
Morocco 32 1988 127 3 
Jordan 32 397 7 0.7 
Palestine 32 308 2 0.4 
Egypt 30 2350 178 2 
India 29 11555 396 0.3 
Kuwait 29 1405 3 0.7 
 Saudi 
Arabia 
25 5862 79 2 
Qatar 25 3711 7 2 
Bahrain 25 1671 7 4 
Taiwan 25 395 6 0.3 
 UAE 24 4933 28 3 
Bangladesh 24 1231 50 0.3 
Cuba 23 766 21 2 
Hong Kong 22 1017 4 0.5 
Oman 21 910 4 0.8 
Reunion 21 391 0 0 
Vietnam 21 297 0 0 
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Dominican 
Republic 
19 3286 183 17 
Brazil 16 25758 1557 7 
Guatemala 16 180 5 0.3 
Philippines 15 5453 349 3 
 Senegal 15 314 2 0.1 
Martinique 15 158 8 21 
 Thailand 14 2643 43 0.6 
Niger 14 570 14 0.6 
Honduras 14 419 31 3 
Burkina 
Faso 
12 528 30 1 
Djibouti 12 363 2 2 
Costa Rica 10 618 3 0.6 
Guinea 10 404 1 0.1 
 Venezuela 10 197 9 0.3 
Panama 8 3574 95 22 
Ivory Coast 8 638 6 0.2 
 Nigeria 7 373 11 0.05 
 Sri Lanka 7 235 7 0.3 
Ghana 6 636 8 0.3 
 Colombia 5 2979 127 2 
Cameroon 5 848 17 0.6 
 Malaysia 3 5072 83 3 
Singapore 1 3252 10 2 
Ecuador -1 7603 369 21 
Kenya -1 225 10 0.2 
 DRC -4 241 20 0.2 
 Indonesia -6 5136 469 2 
Peru -12 10303 230 7 
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Bolivia -19 397 28 2 
Mauritius -20 324 9 7 
Chile -31 7917 92 5 
 South 
Africa 
-33 2415 27 0.5 
Australia -35 6447 63 2 
Argentina -35 2443 108 2 
Uruguay -35 492 8 2 
New 
Zealand 
-37 1386 9 2 
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